Cargando…

Efficacy and Safety of Everolimus in Korean Patients with Metastatic Renal Cell Carcinoma Following Treatment Failure with a Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitor

PURPOSE: The purpose of this study is to assess the efficacy and safety of everolimus in Korean patients with metastatic renal cell carcinoma (mRCC) for whom initial treatment with a vascular endothelial growth factor receptor-tyrosine kinase inhibitor (VEGFr-TKI) has failed. MATERIALS AND METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Kwonoh, Lee, Jae-Lyun, Ahn, Jin-Hee, Lee, Kyoo Hyung, Jeong, In-Gab, Song, Cheryn, Hong, Bumsik, Hong, Jun Hyuk, Ahn, Hanjong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Cancer Association 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4206076/ https://www.ncbi.nlm.nih.gov/pubmed/25036572 http://dx.doi.org/10.4143/crt.2013.154

Ejemplares similares

Adjuvant chemotherapy versus observation after radical cystectomy in patients with node-positive bladder cancer
por: Pak, Sahyun, et al.
Publicado: (2019)

Preserving Renal Function through Partial Nephrectomy Depends on Tumor Complexity in T1b Renal Tumors
por: Yoo, Sangjun, et al.
Publicado: (2017)

The Type of Nephrectomy Has Little Effect on Overall Survival or Cardiac Events in Patients of 70 Years and Older With Localized Clinical T1 Stage Renal Masses
por: Kyung, Yoon Soo, et al.
Publicado: (2014)

Clinicopathological features of Xp11.2 translocation renal cell carcinoma
por: Lim, Bumjin, et al.
Publicado: (2015)

Does epithelioid angiomyolipoma have poorer prognosis, compared with classic angiomyolipoma?
por: Lee, Wonchul, et al.
Publicado: (2018)

Validation of the 2009 TNM Classification for Renal Cell Carcinoma: Comparison with the 2002 TNM Classification by Concordance Index
por: Lee, Chunwoo, et al.
Publicado: (2011)

Long-Term Oncologic Outcomes after Radical Cystectomy for Bladder Cancer at a Single Institution
por: Kwon, Taekmin, et al.
Publicado: (2014)

Safety of Megestrol Acetate in Palliating Anorexia-Cachexia Syndrome in Patients with Castration-Resistant Prostate Cancer
por: Hong, Sungwoo, et al.
Publicado: (2013)

Incidence of Benign Results After Laparoscopic Radical Nephroureterectomy
por: Hong, Sungwoo, et al.
Publicado: (2014)

Is Intravesical Bacillus Calmette-Guérin Therapy Superior to Chemotherapy for Intermediate-risk Non-muscle-invasive Bladder Cancer?: An Ongoing Debate
por: Han, Kyung-Sik, et al.
Publicado: (2015)

Prognostic impact of preoperative statin use after radical nephroureterectomy for upper urinary tract urothelial carcinoma
por: Lim, Ju Hyun, et al.
Publicado: (2015)

Effect of decreased renal function on poor oncological outcome after radical cystectomy
por: Kim, Dongsu, et al.
Publicado: (2023)

Predictive Characteristics of Malignant Pheochromocytoma
por: Park, Junsoo, et al.
Publicado: (2011)

Nomograms for the Prediction of Pathologic Stage of Clinically Localized Prostate Cancer in Korean Men
por: Song, Cheryn, et al.
Publicado: (2005)

Association between serum levels of insulin‐like growth factor‐1, bioavailable testosterone, and pathologic Gleason score
por: Kim, Myong, et al.
Publicado: (2018)

Effects of statin use on the response duration to androgen deprivation therapy in metastatic prostate cancer
por: Jung, Jaeyoon, et al.
Publicado: (2015)

Effectiveness of Adding Docetaxel to Androgen Deprivation Therapy for Metastatic Hormone-Sensitive Prostate Cancer in Korean Real-World Practice
por: Park, Kwonoh, et al.
Publicado: (2023)

Genotypic and Phenotypic Characteristics of Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome in Korean Patients
por: Seo, Ja Young, et al.
Publicado: (2021)

Preoperative Factors Predictive of Posterolateral Extracapsular Extension After Radical Prostatectomy
por: Pak, Sahyun, et al.
Publicado: (2013)

Biochemical Recurrence-Free and Cancer-Specific Survival after Radical Prostatectomy at a Single Institution
por: Kim, Seong Cheol, et al.
Publicado: (2010)

Reduced restenosis and enhanced re-endothelialization of functional biodegradable vascular scaffolds by everolimus and magnesium hydroxide
por: Baek, Seung-Woon, et al.
Publicado: (2022)

Androgen deprivation therapy during and after post-prostatectomy radiotherapy in patients with prostate cancer: a case control study
por: Kim, Myong, et al.
Publicado: (2018)

Prostate-specific antigen response rate of sequential chemotherapy in castration-resistant prostate cancer: the results of real life practice
por: Song, Geehyun, et al.
Publicado: (2013)

Cause of Death in Korean Men with Prostate Cancer: an Analysis of Time Trends in a Nationwide Cohort
por: Park, Jinsung, et al.
Publicado: (2016)

Does Radical Cystectomy Improve Overall Survival in Octogenarians with Muscle-Invasive Bladder Cancer?
por: Yoo, Sangjun, et al.
Publicado: (2011)

Prevalence and clinical significance of incidental (18)F-fluoro-2-deoxyglucose uptake in prostate
por: Kwon, Taekmin, et al.
Publicado: (2015)

Antibiotic prophylaxis with intravenous ceftriaxone and fluoroquinolone reduces infectious complications after transrectal ultrasound-guided prostatic biopsy
por: Lee, Chunwoo, et al.
Publicado: (2015)

Clinical features and prognosis of prostate cancer with high-grade prostatic intraepithelial neoplasia
por: Lee, Donghyun, et al.
Publicado: (2015)

Changing Patterns of Primary Treatment in Korean Men with Prostate Cancer Over 10 Years: A Nationwide Population Based Study
por: Park, Jinsung, et al.
Publicado: (2016)

Prognosis of Prostate Cancer With Other Primary Malignancies
por: Lim, Ju Hyun, et al.
Publicado: (2014)

Is Bladder Tumor Location Associated with Prostate Cancer Detection after Intravesical Bacillus Calmette-Guérin Instillation?
por: Hong, Sungwoo, et al.
Publicado: (2014)

Recent Changes in the Clinicopathologic Features of Korean Men with Prostate Cancer: A Comparison with Western Populations
por: Byun, Seok-Soo, et al.
Publicado: (2012)

Impact of Adjuvant Androgen-Deprivation Therapy on Disease Progression in Patients with Node-Positive Prostate Cancer
por: Park, Sejun, et al.
Publicado: (2011)

Histologic Variability and Diverse Oncologic Outcomes of Prostate Sarcomas
por: Sohn, Mooyoung, et al.
Publicado: (2014)

The association between serum lipid profile and the prostate cancer risk and aggressiveness
por: Suh, Jungyo, et al.
Publicado: (2023)

Safety and efficacy of everolimus in Chinese patients with metastatic renal cell carcinoma resistant to vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy: an open-label phase 1b study
por: Guo, Jun, et al.
Publicado: (2013)

Comparative analysis of oncologic outcomes for open vs. robot-assisted radical prostatectomy in high-risk prostate cancer
por: Lee, Donghyun, et al.
Publicado: (2015)

Stereotactic body-radiotherapy boost dose of 18 Gy vs 21 Gy in combination with androgen-deprivation therapy and whole-pelvic radiotherapy for intermediate- or high-risk prostate cancer: a study protocol for a randomized controlled, pilot trial
por: Kim, Yeon Joo, et al.
Publicado: (2018)

2020 Korean guidelines for the management of metastatic prostate cancer
por: Kim, In-Ho, et al.
Publicado: (2021)

Preoperative Clinical and Pathological Characteristics of pT0 Prostate Cancer in Radical Prostatectomy
por: Park, Junsoo, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_9e3ql3s7mmjubumd7bnlqvetge